For citations:
Li A.A., Geliashvili T.M., Rumyantsev A.A., Pronin A.I., Krylov A.S., Baranova O.D., Parnas A.V., Ilyakov V.S., Vorobyeva D.A. Impressive response to 177Lu-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer refractory to apalutamide, docetaxel and metastasis-directed therapy. Cancer Urology. 2024;20(4):98-103. (In Russ.) https://doi.org/10.17650/1726-9776-2024-20-4-98-103
Email this article 